Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
eli lilly
2
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
alex azar
alliance for aging research
amgen
armo biosciences
autoimmune
avalon ventures
biogen
biotech
biotechnology innovation organization
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
coi pharmaceuticals
correlation ventures
crohn's disease
cytokines
deals
detroit blog main
detroit top stories
drug development
drug pricing
duane schulthess
erica whittaker
fda
fundraising
gvhd
immune checkpoint
indiana blog main
indiana top stories
innovation
What
plans
2
×
administration
advance
angry
anti
benefited
biology
company
cytokine
despite
drug
drugs
enhanced
fear
files
industry
initial
ipo
laying
losing
money
offering
pharma
presidential
price
public
raise
rhetoric
rx
san
scalps
split
suite
synthetic
synthorx
thanks
trump
tweets
Language
Current search:
plans
×
" eli lilly "
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs